Your session is about to expire
← Back to Search
Positive Psychology Intervention for Caregivers of Blood Cancer Patients (PATH-C Trial)
N/A
Waitlist Available
Led By Hermioni L Amonoo, MD, MPP, MPH
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a program that uses activities to make caregivers of cancer patients feel happier and less stressed. The goal is to improve their health and quality of life by boosting positive emotions.
Who is the study for?
This trial is for adult caregivers (18+ years) of patients undergoing allogeneic stem cell transplant at DCFI. They must speak English, be able to complete questionnaires with minimal help, and have close contact with the patient at least twice a week. Caregivers with cognitive deficits that affect their ability to consent or participate are excluded.
What is being tested?
The study tests a Positive Psychology Intervention aimed at reducing caregiver burden by enhancing positive emotions among those caring for blood cancer patients receiving stem cell transplants. It seeks to improve caregivers' quality of life and health outcomes.
What are the potential side effects?
Since this intervention focuses on psychological support rather than medication, traditional physical side effects are not expected. However, participants may experience emotional responses as they engage in the program.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability Rate
Feasibility of the PATH Intervention
Secondary study objectives
Feasibility and acceptability of the PATH intervention assessed by participant ratings of ease and utility on a 10 point likert scale after each weekly intervention session
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: PATH InterventionExperimental Treatment1 Intervention
Participants in the PATH Intervention arm will receive psychosocial support phone calls during week 1 through 9 following enrollment.
After consent procedures, participants will begin an 9-week positive-psychology program involving weekly calls with an interventionist and exercises (i.e. writing a letter of gratitude, identifying personal strengths, planning meaningful and enjoyable activities).
Self-assessment questionnaires to measure positive affect, health behaviors, and overall function before and after completing the Positive Psychology Intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Positive Psychology Intervention
2022
N/A
~190
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Positive Emotion-Based Interventions for caregivers focus on enhancing positive emotions to reduce caregiver burden and improve quality of life. These treatments work by promoting activities that increase positive affect, such as gratitude exercises, mindfulness practices, and engaging in enjoyable activities.
By fostering positive emotions, these interventions help mitigate stress, anxiety, and depression, which are common among caregivers. This is crucial as it not only improves the mental and emotional well-being of caregivers but also enhances their ability to provide effective care for their loved ones.
Find a Location
Who is running the clinical trial?
Brigham and Women's HospitalLead Sponsor
1,666 Previous Clinical Trials
11,840,212 Total Patients Enrolled
Dana-Farber Cancer InstituteLead Sponsor
1,108 Previous Clinical Trials
357,214 Total Patients Enrolled
Hermioni L Amonoo, MD, MPP, MPHPrincipal InvestigatorBrigham and Women's Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: PATH Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger